FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Akorn Sodium Chloride Ophthalmic Ointment Recall

Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile

Akorn, Inc. · Gurnee, IL

Risk level
Class II
Reported by FDA
Sep 14, 2022
Recall ID
D-1496-2022
Check your lot numberHow we source this data

Summary

Akorn recalled Sodium Chloride Ophthalmic Ointment starting Aug 31, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1496-2022 on Sep 14, 2022. Reason: cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause. Status: Terminated.

Why it was recalled

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Product description

Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35

Lot numbers, UPCs & expiration codes

Lot#: 9J58A, 9J58B, Exp 8/31/2022

Where it was sold

USA nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1496-2022
Classification
Class II
Status
Terminated
Recall initiated
Aug 31, 2022
FDA report date
Sep 14, 2022
Quantity
48,636 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-1496-2022, exactly as published.

Show all FDA fields
City
Gurnee
State
IL
Status
Terminated
Country
United States
Event ID
90813
Address
5605 Centerpoint Ct Ste A
Code information
Lot#: 9J58A, 9J58B, Exp 8/31/2022
Postal code
60031-5278
Report date
Sep 14, 2022
Product type
Drugs
Recall number
D-1496-2022
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
48,636 tubes
Termination date
Jun 18, 2024
Reason for recall
cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) tube, Mfg by: Akorn, Inc., Lake Forest , IL 600405, NDC 17478-622-35
Distribution pattern
USA nationwide
Recall initiation date
Aug 31, 2022
Initial firm notification
Letter
Center classification date
Sep 6, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1496-2022, published Sep 14, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls